Dover Advisors LLC Buys Shares of 39,291 The Chemours Company $CC

Dover Advisors LLC bought a new stake in The Chemours Company (NYSE:CC) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 39,291 shares of the specialty chemicals company’s stock, valued at approximately $463,000.

Several other large investors have also modified their holdings of the business. Goldman Sachs Group Inc. grew its position in shares of Chemours by 36.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 3,701,294 shares of the specialty chemicals company’s stock valued at $43,638,000 after purchasing an additional 996,012 shares during the last quarter. Monaco Asset Management SAM grew its position in shares of Chemours by 2,240.7% in the fourth quarter. Monaco Asset Management SAM now owns 702,200 shares of the specialty chemicals company’s stock valued at $8,279,000 after purchasing an additional 672,200 shares during the last quarter. Norges Bank acquired a new stake in shares of Chemours in the fourth quarter valued at approximately $627,000. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Chemours in the fourth quarter valued at approximately $31,000. Finally, Rothschild Investment LLC grew its position in shares of Chemours by 87.0% in the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 1,255 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CC has been the topic of several research reports. Jefferies Financial Group reiterated a “hold” rating and issued a $17.00 price target on shares of Chemours in a research report on Monday, February 23rd. The Goldman Sachs Group increased their price target on shares of Chemours from $14.00 to $18.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. Morgan Stanley increased their price target on shares of Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, May 11th. Alembic Global Advisors reiterated an “overweight” rating and issued a $30.00 price target on shares of Chemours in a research report on Wednesday, May 13th. Finally, Mizuho set a $30.00 price target on shares of Chemours in a research report on Wednesday, May 6th. Six research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Chemours currently has an average rating of “Hold” and a consensus target price of $24.60.

Chemours Stock Up 3.8%

Shares of NYSE CC opened at $23.16 on Wednesday. The Chemours Company has a 1 year low of $9.20 and a 1 year high of $28.67. The firm’s 50 day moving average price is $22.90 and its 200 day moving average price is $17.79. The firm has a market cap of $3.48 billion, a P/E ratio of -8.77 and a beta of 1.39. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.87 and a current ratio of 1.82.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter last year, the business earned $0.13 earnings per share. Chemours’s revenue was up 1.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Chemours Company will post 1.27 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Sunday, May 17th will be given a dividend of $0.0875 per share. The ex-dividend date is Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a yield of 1.5%. Chemours’s dividend payout ratio (DPR) is -13.26%.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.